Clinical trial design optimisation and dose rationale for the treatment of Buruli Ulcer antibiotic combination therapy

被引：0
|
作者：
D'Agate, Salvatore [1 ]
Garcia Barrios, Noelia [1 ]
Millan Placer, Ana Cristina [2 ]
Lucia Quintana, Ainhoa [2 ]
Ramon Garcia, Santiago [3 ]
Della Pasqua, Oscar [4 ]
机构：
[1] UCL, London, England
[2] Univ Zaragoza, Zaragoza, Spain
[3] Fdn ARAID, Zaragoza, Spain
[4] GlaxoSmithKline, Munich, Germany
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2021年 / 87卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OC016
引用
收藏
页码：4882 / 4882
页数：1
相关论文
共 50 条
  • [1] Optimizing β-lactam-containing antibiotic combination therapy for the treatment of Buruli ulcer
    D'Agate, Salvatore
    Velickovic, Peter
    Garcia-Barrios, Noelia
    Ramon-Garcia, Santiago
    Della Pasqua, Oscar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 91 (01) : 179 - 189
  • [2] Risk Factors Associated with Antibiotic Treatment Failure of Buruli Ulcer
    O'Brien, Daniel P.
    Friedman, N. Deborah
    Walton, Aaron
    Hughes, Andrew
    Athan, Eugene
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [3] Functional Limitations after Surgical or Antibiotic Treatment for Buruli Ulcer in Benin
    Barogui, Yves
    Johnson, R. Christian
    van der Werf, Tjip S.
    Sopoh, Ghislain
    Dossou, Ange
    Dijkstra, Pieter U.
    Stienstra, Ymkje
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (01): : 82 - 87
  • [4] All-Oral Antibiotic Treatment for Buruli Ulcer: A Report of Four Patients
    Gordon, Claire L.
    Buntine, John A.
    Hayman, John A.
    Lavender, Caroline J.
    Fyfe, Janet A. M.
    Hosking, Patrick
    Starr, Mike
    Johnson, Paul D. R.
    PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (11):
  • [5] A Clinical Trial of Combination Therapy with Etanercept and Low Dose Cyclosporine for the Treatment of Refractory Psoriasis
    Lee, Eun Ju
    Shin, Min Kyung
    Kim, Nack In
    ANNALS OF DERMATOLOGY, 2010, 22 (02) : 138 - 142
  • [6] Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay
    Converse, Paul J.
    Almeida, Deepak V.
    Tyagi, Sandeep
    Xu, Jian
    Nuermberger, Eric L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)
  • [7] Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load
    Frimpong, Michael
    Agbavor, Bernadette
    Duah, Mabel Sarpong
    Loglo, Aloysius
    Sarpong, Francisca N.
    Boakye-Appiah, Justice
    Abass, Kabiru M.
    Dongyele, Mathias
    Amofa, George
    Tuah, Wilson
    Frempong, Margaret
    Amoako, Yaw A.
    Wansbrough-Jones, Mark
    Phillips, Richard O.
    PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (08):
  • [8] Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease)v
    Chauty, Annick
    Ardant, Marie-Francoise
    Adeye, Ambroise
    Euverte, Helene
    Guedenon, Augustin
    Johnson, Christian
    Aubry, Jacques
    Nuermberger, Eric
    Grosset, Jacques
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) : 4029 - 4035
  • [9] The Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial: Rationale and Design
    Toshio Ogihara
    Masunori Matsuzaki
    Hiroaki Matsuoka
    Kazuaki Shimamoto
    Kazuyuki Shimada
    Hiromi Rakugi
    Seiji Umemoto
    Akira Kamiya
    Norihiro Suzuki
    Hiroo Kumagai
    Yasuo Ohashi
    Shuichi Takishita
    Keishi Abe
    Takao Saruta
    Hypertension Research, 2005, 28 : 331 - 338
  • [10] The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: Rationale and design
    Ogihara, T
    Matsuzaki, M
    Matsuoka, H
    Shimamoto, K
    Shimada, K
    Rakugi, H
    Umemoto, S
    Kamiya, A
    Suzuki, N
    Kumagai, H
    Ohashi, Y
    Takishita, S
    Abe, K
    Saruta, T
    HYPERTENSION RESEARCH, 2005, 28 (04) : 331 - 338
12345